Olivia Manser
Public Communications Contact bei AUTOLUS THERAPEUTICS PLC
Ursprung des Netzwerks ersten Grades von Olivia Manser
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Stifel Nicolaus Europe Ltd.
 Stifel Nicolaus Europe Ltd. Investment Banks/BrokersFinance Stifel Nicolaus Europe Ltd. (SNEL) is a brokerage firm headquartered in London, UK. The firm was founded in 1999 and do-business-as Keefe, Bruyette & Woods Ltd. (KBW). They are a subsidiary of Stifel Europe Holdings Ltd., ultimately owned by Stifel Financial Corp. (NYSE: SF) in the US. SNEL provides Pan-European equity research and sales and trading products for their institutional clients.
73
| Subsidiary | Investment Banks/Brokers | 73 |
| Public Company | Biotechnology | 27 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Olivia Manser
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Founder | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member General Counsel | |
Numis Securities Ltd.
 Numis Securities Ltd. Investment Banks/BrokersFinance Numis Securities Ltd. is an institutional brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of Numis Corp. Plc in (LON: NUM). Numis Securities serves as a corporate broker to several clients across all their sectors, ranging from FTSE 100 to FTSE small-cap companies and AIM-listed companies. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
| University of Bristol | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Panmure Gordon (UK) Ltd.
 Panmure Gordon (UK) Ltd. Investment Banks/BrokersFinance Panmure Gordon (UK) Ltd. (PGL) is the stockbroking subsidiary of Panmure Gordon & Co. Ltd. in Great Britain. Headquartered in London, the firm was founded in 2003 and provides corporate finance advice, distributes and trades securities and produces investment research to UK small and mid-cap corporates and investment companies. PGL has access to capital markets via a range of equity and equity-linked products such as IPOs, accelerated book buildings, placings, rights issues, and bought deals. The firm's institutional equities department provides UK-focused research, sales and trading services to institutional investors in the UK, US and Europe. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Merrill Lynch International
 Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Morgan Stanley & Co. International Plc (MSCI) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Morgan Stanley Investments (UK), ultimately held by Morgan Stanley (NYSE: MS) in the US. MSCI provides a range of brokerage services to corporations, governments and financial institutions. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Canaccord Genuity Ltd.
 Canaccord Genuity Ltd. Investment Banks/BrokersFinance Canaccord Genuity Ltd. (CGL) is the brokerage subsidiary of Canaccord Genuity Group, Inc. (TSE: CF). The firm is headquartered in London and was founded in 1983. CGL provides brokerage services to their clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
| BLUEBIRD BIO, INC. | Biotechnology | Director of Finance/CFO Director/Board Member | |
Cantor Fitzgerald Europe
 Cantor Fitzgerald Europe Investment Banks/BrokersFinance Part of Cantor Fitzgerald LP, Cantor Fitzgerald Europe is a British brokerage company. The company is based in London, UK. The CEOs are Sofocles Sofocleous, Sara Simmons, Juergen Haferkorn. The company was founded in 1945. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Director/Board Member Chairman | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Jefferies International Ltd.
 Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
Citigroup Global Markets Ltd.
 Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Investment Banks/Brokers | Director of Research - Equity Sales & Marketing | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Imperial College London | College/University | Undergraduate Degree Masters Business Admin | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Stockdale Securities Ltd.
 Stockdale Securities Ltd. Investment Banks/BrokersFinance Part of Shore Capital Group Ltd., Stockdale Securities Ltd. is a brokerage firm based in London, UK. The British company was founded in 1963 by Timothy David Feather. Mark Finlay Brown has been the CEO of the company since 2014. Stockdale Securities was acquired by Shore Capital Group Ltd. from Somers Ltd. on March 31, 2019 for $11.72 million. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
Deutsche Bank AG (Broker UK)
 Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Deutsche Bank AG (Deutsche Bank UK) is the UK-based securities brokerage division of Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in London and was founded in 1873. Deutsche Bank provides brokerage services to companies and institutions. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Shore Capital Stockbrokers Ltd.
 Shore Capital Stockbrokers Ltd. Investment Banks/BrokersFinance Shore Capital Stockbrokers Ltd. (Shore Capital) is a broker-dealer firm headquartered in London, UK. Formerly known as Puma Securities Ltd., the firm was founded in 1985 and is a subsidiary of Shore Capital Group Ltd. (LON: SGR). Shore Capital offers corporate clients with edge electronic equities trading platform, which operates alongside a growing equity capital markets division. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Joh. Berenberg, Gossler & Co. KG (United Kingdom) (Berenberg-UK) is the Great Britain-based broker/dealer division of Joh. Berenberg, Gossler & Co. KG, a multinational full-service investment bank in Germany. Headquartered in London, Berenberg-UK was founded in 2003 and provides trading and brokerage services to institutional and corporate clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Commerzbank AG (UK)
 Commerzbank AG (UK) Investment Banks/BrokersFinance Commerzbank AG (UK) is the UK brokerage division of Commerzbank AG (FR: CBK) in Germany. Based in London, they engage in equity, debt and derivative instrument trading, investment banking, public finance and treasury, interest-rate and currency management, as well as corporate finance. In 2009 Dresdner Bank was acquired by and merged into Commerzbank and the London-based activities of Dresdner Kleinwort Securities absorbed into Commerzbank AG (UK). The firm provides capital markets services, corporate advisory, risk management, research and lending services focused on equity, corporate and emerging-market debt, derivatives and money market products. Their clients are European and international corporations, institutions and government entities. In terms of corporate finance they offer financial advisory as well as execution capabilities for a wide range of corporate finance-related transactions on a global basis. Their primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Singer Capital Markets Securities Ltd.
 Singer Capital Markets Securities Ltd. Investment Banks/BrokersFinance Part of N1 Singer Ltd., Singer Capital Markets Securities Ltd. is a brokerage firm. The company is based in London, UK. The British company was founded in 2012 by Timothy Bruce Cockroft, Peter Welch. Timothy Bruce Cockroft has been the CEO since 2012. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| The University of Southampton | College/University | Undergraduate Degree Undergraduate Degree | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
Goodbody Stockbrokers UC
 Goodbody Stockbrokers UC Investment Banks/BrokersFinance Goodbody Stockbrokers UC (Goodbody) is an institutional brokerage firm headquartered in Dublin, Ireland. The firm was founded in 1877 and is a subsidiary of government-owned AIB Group Plc (ISE: AIBG; OTCMKTS: AIBGY). Goodbody offers a traditional stockbroking service to their institutional client base. They cover several stocks via Research and Execution. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree | |
Keefe, Bruyette & Woods Ltd.
 Keefe, Bruyette & Woods Ltd. Investment Banks/BrokersFinance Part of Stifel Financial Corp., Keefe, Bruyette & Woods Ltd. is a wealth management and British investment banking company that helps individuals and organizations achieve their financial objectives. The company is based in London, UK. KBW's Equity Sales & Trading Division offers financial industry-specific knowledge and access to research and capital markets transactions. Additionally, 67 KBW employees lost their lives on September 11, 2001, and the company has since prioritized assisting the affected families through the KBW Family Fund. The company was founded in 2004. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
JPMorgan Securities Plc
 JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Sales & Marketing Analyst-Equity | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Director/Board Member Private Equity Investor | |
Société Générale SA (UK)
 Société Générale SA (UK) Investment Banks/BrokersFinance Société Générale SA (UK) (Société Générale UK) is the Great Britain-based brokerage division of Societe Generale SA (XP: GLE, ADR: SCGLY) in France. Headquartered in London, Société Générale UK was founded in 1993 and provides broking services. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity |
Statistik
International
| Vereinigtes Königreich | 33 |
| Vereinigte Staaten | 13 |
| Deutschland | 3 |
| Norwegen | 2 |
| Schweiz | 2 |
Sektoral
| Finance | 26 |
| Health Technology | 16 |
| Consumer Services | 9 |
| Commercial Services | 2 |
| Health Services | 2 |
Operativ
| Director/Board Member | 180 |
| Analyst-Equity | 164 |
| Corporate Officer/Principal | 79 |
| Independent Dir/Board Member | 54 |
| Chairman | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| John Johnson | 40 |
| Kapil Dhingra | 39 |
| Martin Murphy | 33 |
| William Young | 32 |
| John Berriman | 24 |
| Joseph Anderson | 19 |
| Cynthia Butitta | 16 |
| Simon Bragg | 15 |
| Robert Azelby | 15 |
| Linda Bain | 15 |
| Jay Backstrom | 15 |
| Andrew Oakley | 14 |
| Christian Itin | 12 |
| Thomas Patrick Mulroy | 11 |
| Robert Iannone | 11 |
- Börse
- Insiders
- Olivia Manser
- Unternehmensverbindungen
